Dr Sharat Maxivision Eye Hospitals Llp Profile
Key Indicators
- Obligation of Contribution ₹ 34.82 Cr
- Company Age 5 Year, 6 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 13.58 Cr
About Dr Sharat Maxivision Eye Hospitals Llp
Company Details
-
Location
Warangal, Telangana, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN/FCRN
AAQ-1759
-
Incorporation Date
06 Aug 2019
-
Date of Accounts and Solvency Statement
31 Mar 2023
-
ROC Code
Roc-Hyderabad
-
Company Classification
Limited Liability Partnership
Industry
Who are the key members and board of directors at Dr Sharat Maxivision Eye Hospitals Llp?
Designated Partners (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Gomathy Kulandaivelu
|
Designated Partner | 07-Oct-2019 | Current |
|
Chilukuri Babu
|
Designated Partner | 06-Aug-2019 | Current |
|
Chilukuri Konduri
|
Designated Partner | 06-Aug-2019 | Current |
Financial Performance of Dr Sharat Maxivision Eye Hospitals Llp.
Enhance accessibility to Dr Sharat Maxivision Eye Hospitals Llp's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Dr Sharat Maxivision Eye Hospitals Llp?
Unlock access to Dr Sharat Maxivision Eye Hospitals Llp's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
-
Neuberg Abha Laboratory Private LimitedGomathy Kulandaivelu is a mutual person
-
Stakeboat Ventures LlpGomathy Kulandaivelu is a mutual person
-
Aloka Trivitron Medical Technologies Private LimitedGomathy Kulandaivelu is a mutual person
-
Trivitron Healthcare Private Limited
Gomathy Kulandaivelu is a mutual person
-
Apollo Dialysis Private LimitedGomathy Kulandaivelu is a mutual person
-
Dr. Ramalinga Reddy Maxivision Eye Hospitals Private LimitedGomathy Kulandaivelu is a mutual person
Charges (Loans)
₹13.58 Cr
₹0
Charges Breakdown by Lending Institutions
- Hdfc Bank Limited : 13.58 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 05 Apr 2021 | Hdfc Bank Limited | ₹13.58 Cr | Open |
How Many Employees Work at Dr Sharat Maxivision Eye Hospitals Llp?
Dr Sharat Maxivision Eye Hospitals Llp has a workforce of 197 employees as of Mar 29, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Dr Sharat Maxivision Eye Hospitals Llp, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Dr Sharat Maxivision Eye Hospitals Llp's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.